title: Costs of rituximab maintenance treatment in patients with refractory rheumatoid arthritis.
authors.forename: A
authors.initials: A
authors.lastname: Risselada
authors.forename: J
authors.initials: J
authors.lastname: Tekstra
authors.forename: Y K
authors.initials: YK
authors.lastname: Teng
authors.forename: P M J
authors.initials: PM
authors.lastname: Welsing
authors.forename: F
authors.initials: F
authors.lastname: Breedveld
authors.forename: J M
authors.initials: JM
authors.lastname: van Laar
authors.forename: J W J
authors.initials: JW
authors.lastname: Bijlsma
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009426:Netherlands; D000069283:Rituximab
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D000069283:Rituximab